Mechanisms of harmol sulfate biliary excretion in mice and rats
暂无分享,去创建一个
[1] Kim L R Brouwer,et al. The Important Role of Bcrp (Abcg2) in the Biliary Excretion of Sulfate and Glucuronide Metabolites of Acetaminophen, 4-Methylumbelliferone, and Harmol in Mice , 2006, Molecular Pharmacology.
[2] Kim L. R. Brouwer,et al. Differential Involvement of Mrp2 (Abcc2) and Bcrp (Abcg2) in Biliary Excretion of 4-Methylumbelliferyl Glucuronide and Sulfate in the Rat , 2006, Journal of Pharmacology and Experimental Therapeutics.
[3] Kim L R Brouwer,et al. Integration of hepatic drug transporters and phase II metabolizing enzymes: mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[4] A. Dahan,et al. Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[5] K. Brouwer,et al. Hepatobiliary Disposition of the Metabolically Stable Opioid Peptide [d-Pen2, d-Pen5]-Enkephalin (DPDPE): Pharmacokinetic Consequences of the Interplay between Multiple Transport Systems , 2004, Journal of Pharmacology and Experimental Therapeutics.
[6] Yuichi Sugiyama,et al. ABCG2 Transports Sulfated Conjugates of Steroids and Xenobiotics* , 2003, Journal of Biological Chemistry.
[7] M. Vore,et al. The effect of troglitazone biliary excretion on metabolite distribution and cholestasis in transporter-deficient rats. , 2001, Drug metabolism and disposition: the biological fate of chemicals.
[8] C. Funk,et al. Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat. , 2001, Molecular pharmacology.
[9] T. Litman,et al. Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR. , 1999, Cancer letters.
[10] C. Goresky,et al. Transport, binding, and metabolism of sulfate conjugates in the liver. , 1994, Chemico-biological interactions.
[11] G. Mulder,et al. Secretion of the organic anion harmol sulfate from liver into blood. Evidence for a carrier-mediated mechanism. , 1985, Biochemical pharmacology.
[12] K. Pang,et al. Retrograde perfusion to probe the heterogeneous distribution of hepatic drug metabolizing enzymes in rats. , 1981, The Journal of pharmacology and experimental therapeutics.
[13] G. Mulder,et al. UDP glucuronyltransferase and phenolsulfotransferase from rat liver in vivo and in vitro--IV. Species differences in harmol conjugation and elimination in bile and urine in vivo. , 1975, Biochemical pharmacology.
[14] C. Klaassen,et al. Species variation in toxication and detoxication of acetaminophen in vivo: a comparative study of biliary and urinary excretion of acetaminophen metabolites. , 1988, The Journal of pharmacology and experimental therapeutics.